Summary: Assays for the determination of serum -N-acetylglucosaminidase (EC 3.2.1.50) activity are described employing p-nitrophenyl-N-acetyl-a-D-glucosaminide, phenyl-N-acetyl-a-.D-glucosaminide, and UDP-N-acetylglucosamine as substrates. A log normal distribution of the serum enzyme activity was found. The determination of serum -N-acetylglucosaminidase activity proved to be a valuable tool for the recognition of homozygous and heterozygous carriers of the Sanfilippo B gene.
Introduction
of the mucopolysaccharidoses by serum infusions, the The inactivity of -N-acetylglucosaminidase (EC pinocytotic uptake and the biological action of the 3.2.1.50) has been shown to be the basic defect in mucoKmm enz y me * Sanfilippo B fibroblasts were studied, polysaccharidosis III B {Sanfilippo B disease), an inherited disorder of heparan sulfate catabolism (1, 2) . The Materials and Methods enzyme deficiency has been demonstrated so far in liver, kidney, fibroblasts, serum and urine. Phenyl-N-acetyl-a-/>-glucosammide was kindly provided by gene (3) . In the present paper the physical and kinetic Dr G Mersmann. properties of normal serum -N-acetylglucosaminidase Ampholines pH 4 _ 6 and pH 5 _ 8 were obtained from LKB are described. As there are insufficient experimental data Produkter AB (Stockholm), Na 2 35 SO 4 (carrier-free) from for a critical evaluation of enzyme replacement therapy Amersham-Buchler. All other reagents were of analytical grade.
v. Figura, L gering and Kresse: Serum α-N-acetylglucosaminidase Determination of serum α-N-acetylglucosaminidase activity Sera were assayed either within 9 hours after blood withdrawal, or after storage at -20 °C for up to 8 months. Three different substrates were employed in the determination of enzyme activity:
In test I the reaction mixture consisted of 0.01 mol/1 p-nitrophenyl-N-acetyl-a-£-glucosaminide, 0.0375 mol/1 sodium citrate pH 3.8, 0.2 g/1 NaN 3 and 0.2 ml serum, final volume 0.5 ml. After incubation for 3-36 hours at 37 °C deproteinization was performed with 0.2 ml 0.825 mol/1 HC10 4 . 0.5 ml of the supernate was treated with 1.0 ml 0.4 mol/1 glycine/NaOH buffer, pH 10.4. Readings were made at 430 nm.
In tests II and III p-nitrophcnyl-N-acetyl-a-Z)-glucosaminide was replaced by 0.006 mol/1 phenyl-N-acetyl-a-^-glucosaminide or 0.01 mol/1 UDP-N-acetylglucosamine, respectively. After deproteinization with 0.2 ml 0.152 mol/1 uranyl acetate the N-acetylglucosamine liberated was determined by theMorganElson reaction (4). 0.2 ml of the supernate was treated with 10 jul 2 mol/1 KOH and 40 μΐ 0.8 mol/1 sodium tetraborate, pH 9.2, and the mixture was kept for exactly 4 minutes in a boiling water bath. Following the addition of 1.2 ml of tenfold diluted Ehrlich''s reagent, the colour was developed by incubation for 20 minutes at 37 °C. Readings were made at 546 nm.
Other methods Electrofocussing was done in a 440 ml column (LKB Produkter AB) according to the instructions in the producer's manual. The determinations_pf Sanfilippo B corrective factor activity and-α-N-acetylglucosaminidase activity in cultivated skin fibroblasts were performed as described previously (2) .
Results

Methodology of serum α-N-acetylglucosaminidase determination
Using p-nitrophenyl-N-ace ty l-a-D-glucosaminide, phenyl-N-acetyl-a-D-glucosaminide and UDP-N-acetylglucosamine as substrates for the a-N-acetylglucosaminidase, N-acetylglucosamine is liberated at a constant rate for a least 24 hours under the conditions described.
As shown in Table 1 serum α-N-acetylglucosaminidase exhibits the highest activity towards UDP-N-acetylglucosamine, while /7-nitrophenyl-N-acetyl-a-D-glucosaminide is cleaved at the lowest rate. No age-dependence of the enzyme activity was found. The small number of 0-1 year old individuals investigated (n == 6), however, did not allow a correct statistical, comparison of this group with other age-groups.
A log normal distribution was found for the serum α-Nacetylglucosaminidase activity (Fig. 1 ).
Since the determination of p-nitrophenolate is easier and quicker to perform than that of N-acetylglucosamine, Deproteinization has to be carried out with a neutral salt if the N-acetylglucosamine is to be measured by the Morgan-Elson reaction. Unprecipitated uranyl acetate in the supernate, however, depresses colour developement in the Morgan-Elson reaction by 20% in a sample with a serum content of 70 g/1, and a variation in the serum protein concentration of ± 10% modifies the absorbance by ± 5%. In Table 2 the values are not corrected for the effect of uranyl acetate or for variations in the protein content. The pH dependence of the enzyme activity varied with the substrates used (Fig. 3) . Using phenyl-N-acetyl-a-Z)-glucosaminide a broad pH optimum with a maximum at pH 4.3 was found, whereas withp-nitrophenyl-N-acetyla-£>-glucosaminide a second pH optimum at pH 7.6 has invariably been observed in addition to an optimum at . UDP-N-acetylglucosamine is cleaved maximally at pH 9,7 and pH 4.7. N-acetylglucosamine is liberated from UDP-N-acetylglucosamine not only by the action pf the α-N-acetylglucosaminidase but also by the-combined action of a nucleotide pyrophosphatase and orthophosphoric acid monoester phosphatase, the latter of which can be inhibited by addition of ATP, ADP or AMP. Figure 4 shows the hydrolysis of UDP-N-acetylglucosamine in the presence and absence of 10 mmol/1 AMP. The addition of AMP reduces the rate of hydrolysis by 73% at pH 9.7 and by 18% at pH 4.5.
The enzyme activity is completely destroyed after 10 minutes heating at 70 °C.
The influence of several bivalent cations at a concentration of 10 mmol/1 were tested on a-N-acetylglucosaminidase activity. lation of sulfated mucopolysaccharides as previously described (2) . In Table 2a comparison of the corrective activity of serum α-N-acetylglucosaminidase and urinary α-N-acetylglucosaminidase is given. On administration of equal amounts of enzyme activity the corrective activity brought about by the serum enzyme is only one twelvth of that of the urinary enzyme. Mixing experiments gave the expected intermediate values. The reduced corrective activity of the serum enzyme is not due to a diminished activity towards the stored heparan sulfate. As shown in Table 3 the intraceilular enzyme level obtained after administration of the serum enzyme is also one twelfth of that obtained after application of an equal amount of urinary enzyme.
Discussion
In this paper the determination of serum a-N-acetylglucosaminidase activities with three different substrates is described. All three substrates are suitable for the diagnosis of homozygous and heterozygous carriers of the Sanfilippo B gene. For clinical purposes, however, p-nitrophenyl-N-acetyl-a-/)-glucosaminide is the most convenient substrate, since the liberated p-nitrophenolate is readily measured. The applicability of UDP-Nacetylglucosamine is limited by the fact that even at pH 4.7 the rate of cleavage by enzymes other than a-Nracetylglucosaminidase is more than 20%.
The data obtained for pH optimum and kinetic behavior of serum α-N-acetylglueosaminidase agree well with data found for α-N-acetylglucosaminidase from human urine (4), bovine spleen (5, 6), pig liver (7) and rat testis (8) , and the heat stability is also in accordance with reported data (8, 1) . On the other hand characteristic differences were found in the isoelectric points of urinary and serum α-N-acetylglucosaminidase, being pH 5.52 (4) and pH 4.34, respectively. It is therefore concluded that the urinary enzyme is not derived from the serum by simple ultrafiltration without further modification.
Fratantoni et al. (10) have shown that in the mucopolysaccharidoses the deranged catabolism of mucopolysaccharides can be normalized in cultivated fibroblasts by the addition of the deficient enzyme to the culture medium. These observations initiated a number of therapeutic trials to improve the clinical picture by infusions of whole blood (11), plasma (11) (12) (13) (14) (15) (16) , serum (17) or leukocytes (18) . Contradictory results were reported. For the only therapeutic attempt reported for Sanfilippo B disease (16) no improvement was observed. Studies on the pinocytotic uptake and intracellular action of a-Nacetylglucosaminidase in cultured Sanfilippo B fibroblasts have been reported so far only for the enzyme from human urine (19) and placenta (20) . Under the assumption that the serum enzyme has the same properties as the urinary enzyme with regard to pinocytosis and intracellular action it was calculated that per g cell protein, 80 ml of serum would be needed for half-maximal reduction of the accumulated mucopolysaccharides. After the administration of the serum ejizyme the catalytic activity available intracellularly for metabolic correction is>however, more than one order of magnitude lower than after the administration of the urinary enzyme. It has to be concluded therefore that enzyme replacement therapy in Sanfilippo B disease by serum infusions will not result in measurable specific effects.
